Aging is a complex phenomenon that has detrimental effects on tissue homeostasis. The skeletal muscle is one of the earliest tissues to be affected and to manifest age-related changes such as functional impairment and the loss of mass. Common to these alterations and to most of tissues during aging is the disruption of the proteostasis network by detrimental changes in the ubiquitin-proteasomal system (UPS) and the autophagy-lysosomal system (ALS). In fact, during aging the accumulation of protein aggregates, a process mainly driven by increased levels of oxidative stress, has been observed, clearly demonstrating UPS and ALS dysregulation.
Introduction
The musculoskeletal system accounts for approximately 40% of the total body mass and includes the bones, the skeletal muscles, the joints and the chondroid tissue [1] . Together, all components provide support and structure for the body. These tissues enable movement, protect internal organs and serve as a residence for important signaling and metabolic molecules. The bone tissue accumulates calcium to ensure nerve and muscle function [2] . Furthermore, muscles store over 80% of carbohydrates especially in the form of glycogen [3] . The development of the musculoskeletal system is a stepwise process initiated by condensation of mesodermal mesenchymal precursors at the sites of future bones followed by the differentiation of the precursors into chondrocytes to form the chondroid tissues or into osteoblasts for the bone formation [4] . After formation of the musculoskeletal system there is a continuous remodeling throughout life due to regeneration processes after damage and by the different levels of mechanical stress. Accordingly, increased mechanical forces can arise by an elevation of anabolic activation either through higher physical activity directly generated through muscle action or indirectly through endocrine regulation. Contrariwise, decreased mechanical loads can lead to a dramatic change in the musculoskeletal system like in immobilized individuals through bed rest or less commonly, after space flight [5] . During human growth phase the bone and muscle mass increase dramatically and proportionally to each other. The peak in bone and muscle mass takes place around 25-35 years of age [6] . The interaction between tissues is important for body homeostasis and in fact the bone and the muscle influence each other positively, as a healthy bone formation is associated with resting muscle tension and muscle mass is influenced by bone size and strength [7] . In recent years, it has been suggested that muscle building therapies could improve bone health such as activin signaling inhibitors, which suppress the effect of myostatin, a musclederived hormone deficiency of which results in increased muscle mass and thus indirectly triggers an anabolic effect on the bones [8] . Depending on the type of stimulus, the muscle phenotype can be reshaped. Exercise positively correlates with optimal muscle function, whether aging and simply disuse can negatively impact muscle function and body homeostasis. It is the purpose of this review to focus on the how aging affects the muscle over time and how it leads to its dysfunction.
Aging is a time-dependent physiologic process leading to a persistent functional decline of cells, tissues and organs [9] . It is the single biggest risk factor for the development and establishment of human chronic diseases. The aging process is however a complex phenomenon which comprises several changes during progression of life such as low steady state increase in inflammation, oxidative stress, DNA mutations, mitochondrial dysfunction, accumulation of senescent cells and the loss of proteostasis [27, 28] . Studying the aging process has become particularly important due to the increment on life expectancy and because aging itself sets the stage for the development of age-related diseases (ARD), such as cancer, neurodegenerative diseases including Alzheimer's (AD) and Parkinson's Diseases (PD), and metabolic dysfunction as the one seen in Metabolic Syndrome (MetS), a group of disorders that includes insulin resistance, obesity and type 2 diabetes. These diseases are strongly associated with the aging process itself [31] , for example, aging and cancer exhibit diminished DNA repair ability contributing to increased genomic instability [32] . Moreover, common to AD dementia and aging progression, are both telomere length shortening and telomerase activity decrease [33] highlighting a positive correlation between them. Another example includes mitochondrial dysfunction, a widely described hallmark of aging, now associated with several ARDs in which are included cancer and cardiovascular diseases [8, 34] just to mention a few. Furthermore, diabetes and cardiovascular diseases display augmented inflammation which also seems to be critical in the aging process [35] . The study of muscle aging has gained the attention of the scientific community in the last decades especially due to its early manifestations in life. In fact, muscle loss is one of the earliest events regarding tissue aging having a dramatic impact in overall metabolism and homeostasis.
Pronounced age-related changes mainly occur after the age of 50 years [10, 11] , but muscle and musculoskeletal aging already starts around 25-30 years of age. It is known that (I) the bone mass and mineral content decrease which in contrast increases the risk of fractures, (II) muscles lose size and strength leading to fatigue and weakness and (III) the joint stiffness rises which decreases the flexibility [12, 13] . Muscles normally account for most of the musculoskeletal tissue damage. Elderly lose approximately 1% of muscle mass and 3% of muscle strength each year [14] . The prevalence for muscle mass and strength loss is 5-13% in the 60-70 years old population and 11-50% over 80 years [15] . The consequence is poor endurance, physical inactivity, slow gait speed (a common walk test) and decreased mobility that render lower quality of life [16, 17] . The age-related modifications are also associated with an increased risk of all-cause mortality [18] . The loss of muscle mass and strength is caused by a progressive atrophy highlighted by the loss of muscle fibers, reduced motor neuron input and impaired function of contractility within each fiber [19] . At a molecular level, the skeletal muscle mass seems to be highly dependent and regulated by protein homeostasis (hereafter referred to as proteostasis) mechanisms, in which are included protein synthesis, protein folding, clearance and trafficking, coordinated by signaling networks to maintain a balanced and functional proteome [20] .
Skeletal muscle aging and the progression of age-related diseases
Cells and tissues age at different rates [21, 22] and the skeletal muscle has become an attractive tissue to study the rates of age-related changes, due to the early loss of muscle mass in sedentary humans at 25 years of age and up to 40% at the age of 70 [23] . This mass loss leads to the reduced functional and metabolic performance, which strongly correlates with increased frailty, morbidity and early mortality [24] . Sarcopenia is a muscle loss syndrome characterized by progressive and generalized degenerative loss of skeletal muscle mass, quality, and strength during aging [25] [26] [27] . It has been recognized as a geriatric syndrome, and in mice, the musculoskeletal disease exhibits a significant gene overlap with aging-related genes [28] .
The importance of understanding muscle aging is shown by human epidemiological studies that implicated skeletal muscle aging as an important risk factor for the development of ARD, such as cancer, AD, MetS and chronic heart failure [29] [30] [31] [32] [33] . Furthermore, these correlations seem to be dependent on a metabolically dysfunctional skeletal muscle, suggesting it to be a key regulator of human tissue aging. In fact, many studies have shown the ability of the skeletal muscle to control the pace of other tissues metabolism or aging. Interestingly, muscle-specific overexpression of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1-α) in mice can enhance ß-oxidation in the liver and decrease insulin resistance typical of aging [34] . Strenuous aerobic exercise in humans can impact systemic aging and decrease mortality [33, 35] . Remarkably, an exercised muscle, via valine metabolism, is able to secret several myokines such as β-aminoisobutyric acid that improves several metabolic features in the body such as the expression of brown adipocyte-specific genes in white adipose tissue (WAT), the so-called beiging effect, and enhances fatty acid β-oxidation in hepatocytes both in vitro and in vivo. Furthermore, the skeletal muscle can induce a brown adipose-like phenotype in pluripotent stem cells and increase glucose homeostasis in mice [36] which might contribute to the delaying metabolic complications of aging. Moreover, human exercise was found to be inversely correlated with cardiometabolic risk factors and this is connected to the skeletal muscle [36] .
At a molecular level the muscle skeletal aging shows also distinct features. For example, gene expression analyses revealed different profiles. It was observed that when comparing the skeletal muscle of 20-29 to 65-71 year-old women the latter exhibited more than 40 genes related to "proteins binding to pre-mRNAs" or "mRNAs" to be highly expressed, whereas more than 100 genes involved in "energy metabolism" were downregulated, this is a clear aging profile since energy metabolism is known to decline over time. Interestingly, older muscle showed cyclin-dependent kinase inhibitor 1 (p21) as one of the most abundant genes, a protein responsible for halting the cell cycle, and possibly reflecting DNA damage accumulation during aging. Another study showed that the older muscle displayed a higher number of transcripts, increased number of spliced transcripts or increased cellular heterogeneity [37, 38] . This points to the dedifferentiation of the tissues and might account, at least partially, to the dysfunction of the muscle during aging.
Thus, the muscle tissue seems to be susceptible to aging shown by DNA damage, unspecific spliced variants and cellular heterogeneity, features previously described as aging hallmarks [39] .
Interestingly, as shown previously, many of the well-studied molecular pathways of aging were characterized by studies that focused on specific diseases or mechanisms such as the sirtuins [40] or/and the insulin/IGF-1 axis [41] . These pathways were identified when interventions were employed and shown to delay the onset of aging and extended life-span in many model organisms employed. One important intervention was calorie restriction (CR), which helped to decipher the molecular pathways of aging, especially using C. elegans as a model [42] . CR refers to a decrease in food intake without malnutrition. The level of restriction ranges from 10% to 50%, increasing lifespan in a wide variety of organisms such as C. elegans, D. melanogaster, and Rhesus monkeys. It also delays the age-related functional decline in rodents and monkeys [43] . For example, Edwards and colleagues found that the skeletal muscle of 25-month old mice showed increased activity of p53 and activated a p53-coordinated transcriptional program towards apoptosis, compared to the muscle of young 5-month old mice. Remarkably, mice under CR displayed 77% reduced expression levels of the same p53-dependent genes, supporting the idea that CR ameliorates age-related changes [44] . In humans, CR reduces age-related risk factors such as diabetes, cardiovascular disease and cancer [45] . To date, some mechanisms are known such as the ability of CR to block both mechanistic target of rapamycin (mTOR) and insulin growth-factor-1 (IGF-1) signaling pathways, allowing AMP-activated protein kinase (AMPK) to increase activity, regulating cellular energetics and longevity [46] . Another example shows that, in the skeletal muscle, CR leads to the expression of Forkhead box O (FOXO) transcription factor dependent genes, which include DNA repair enzymes such as DNA damage binding protein 1 (DDB1) and antioxidant enzymes such as superoxide dismutase 2 (SOD2), further supporting the anti-aging role of CR. FOXO transcription factor family is also involved in activating proteolytic mechanisms that allow cellular detoxification from waste products. This will be later on the focus of this review.
Other strategies have been shown to reverse skeletal muscle aging. For instance, specific biomolecules have been identified and proven to have the ability to delay or even recover aged muscle [47] . Interestingly, the authors have shown by means of parabiosis (in this case refers to the joint circulatory connection between young and aged mice), that "young" blood contained rejuvenating factors able to restore the muscle regenerative capacity of old mice. Furthermore, the authors were able to identify the growth differentiation factor 11 (GDF11) to be the main factor for the regeneration ability. Moreover, by supplementation studies with GDF11, it was sufficient to restore genomic integrity in the aged muscle stem cells, which likely increase the muscle regenerative potential. Furthermore, increased GDF11 levels in aged mice also improved muscle structural and functional features and increased strength and endurance exercise capacity [47] .
Another important and consistent feature of muscle aging is the loss of proteostasis. In fact, this has been proposed as being one of the major hallmarks of aging. As a clear sign of proteostasis disruption is the accumulation of aggregated proteins. This seems to be true in many aging models such as bacteria E.coli, the worm C. elegans, in mice and even in humans, where protein aggregation was shown to increase during skeletal muscle aging [48] . Proteostasis loss and its aggravation can, respectively, promote and accelerate the aging process and its enhancement is associated with life span extension [49] . Furthermore, accompanying aging is oxidative stress, which has been widely described as a main contributor to the loss of muscle mass and function during aging. The increased oxidative damage in the muscle leads to structural and functional alterations in the mitochondria which regulate the energy supply, redox reactions and apoptosis [50] . Human [51, 52] and rodent [53, 54] studies have shown an age-dependent increase in products of oxidative damage such as protein oxidation. Moreover, a correlation between age and changes in reactive oxygen and nitrogen species was recently found in skeletal muscle from young and old rodents [55] , therefore in order to avoid the accumulation of toxic oxidized proteins, cells rely on proteolytic mechanisms that ensure proteostasis.
Proteostasis loss as a hallmark of aged muscle
The loss of proteostasis is caused by the dysregulation in the crosstalk between protein synthesis and degradation mechanisms or simply by the impairment of one in detriment of the other. This affects the maintenance and function of the muscle [56] . To support this view, the aged muscle protein synthesis was investigated in respect to its basal rates and in response to anabolic stimuli such as physical activity (resistance exercise) and food intake in elderly humans [57, 58] . While some studies report contradictory results for basal protein synthesis rates, there is increasing evidence that protein synthesis in response to anabolic stimuli is reduced in the aged muscle, suggesting that the aged muscle becomes less responsive to external stimuli [57, 58] . Besides alterations in muscle protein synthesis, age-related changes in protein degradation systems have been reported [59] [60] [61] . In general, skeletal muscle contains at least four proteolytic systems: the calcium-and caspase-dependent pathways, the ubiquitin-proteasomal system (UPS) and autophagy-lysosomal system (ALS) [62] . Since the UPS and ALS are by far the most active proteolytic systems with regard to total protein turnover, we decided to focus our review on these two proteolytic systems in muscle.
The UPS system in the muscle
The UPS plays a pivotal role in protein degradation as shown by several publications in muscle [56, 60, 62, 63] and other tissues and cell types [64, 65] . This system is divided in two main steps: polyubiquitination of the to-be-degraded protein and its recognition and degradation by the proteasome where it cleaves the tagged protein into peptides and amino acids, which can be reused for de novo synthesis. Regarding the first, polyubiquitination involves a stepwise process starting with the ATP-dependent E1 ubiquitin-activation enzyme which activates ubiquitin at its C-terminus, followed by a transfer of the activated ubiquitin to an E2 ubiquitin-conjugation enzyme. This type of enzyme disposes the ubiquitin for conjugation with an E3 ubiquitinligase, which is able to recognize and transfer the ubiquitin specifically to the substrate [56, [66] [67] [68] [69] . After the completion of the process, the tagged protein is recognized by a multiproteolytic complex, named proteasome, composed by a 19S regulatory cap and a 20S proteolytic core, where the protein is actually cleaved. The 20S proteasome by itself is able to recognize and degrade unfolded damaged proteins and oxidized proteins. The core comprises α and β type subunits, being the latter type responsible for its proteolytic activity. The β subunits that account for proteolysis are the β1 (caspase-like activity), β2 (trypsinlike activity) and β5 (chymotrypsin-like activity) subunits [68] . Together with the proteolytic core (20S), the ATPase-containing 19 S regulator caps form an ATP-dependent complex, named 26 S proteasome, responsible for degradation of the majority of the natively-folded proteins [66, 67] . Its relevance in muscle physiology is shown by studies which have demonstrated a decline in proteasomal activity during aging. For example, Strucksberg and colleagues [60] compared the proteasomal activity of quadriceps femoris muscles from mice of two different ages (1.5 and 20 months) and found around 60% decrease in the activity from the aged animal group. Hwee et al. have also observed not only a decrease in proteasomal activity in old mice but also in fiber cross-section area and muscle mass [62] . Another report compared changes in proteasomal activity in rats with different ages such as 4, 18, 24, 29 and 34-months of age, and found that the 20 S proteasomal activity was increased in rats up to 29-months old but decreased in the 34-month old animals. However, in opposite to these variations, the quantity of ubiquitin-linked proteins remained unaltered. This indicates that the 20 S proteasome plays a critical role in muscle atrophy during aging [70] . Interestingly, Altun and colleagues described a different mechanism where they showed that 30-months old sarcopenic rats had actually higher proteasomal activity than young counterparts, as well as higher content in 26 S proteasomes [63] . Another study supports the increase in proteasomal activity in rats with 35-months when compared with young 8-months old ones [71] . This increase in proteasomal activity was correlated with an increase in ubiquitin ligases levels [63, 71] . In muscle, specific E3 ligases are critical for protein degradation such as the Muscle RING Finger 1 (MuRF1) and the Muscle Atrophy F-box (MAFbx, also known as Atrogin-1) and thought to be key regulators of proteasomal turnover contributing to the muscle atrophy [72] . In fact, these atrogenes ("atro" from atrophy) are highly expressed in several atrophy conditions such as those that show denervation, during fasting, development of diabetes mellitus, after corticoids administration and even during sepsis [73, 74] , being dramatically less expressed in resting muscle [75] . Knockout (KO) mice for different atrogenes show reduced muscle atrophy after denervation, after experimentally crushing the sciatic nerve, leading to a disuse-mimicking process in the lower limb [76] . Hwee compared different proteasomal activities between wild type (WT) and MuRF1 KO mice [62] and found that in the WT mice there was a decrease of around 40% in 20 S and 26S chymotrypsin-like activity, while in MuRF1 KO mice, the activity was not changed or solely slightly decreased, suggesting a role for this atrogene in muscle protein degradation [62] . Another KO model for proteasome complex component, the regulatory particle triple-A ATPase 3 (Rpt3), an essential subunit of the 26 S proteasome necessary for most of substrates degradation, was associated with an increase in the amount of E3 ubiquitin ligases. It was suggested that this increase contributed to the accumulation of ubiquitinated proteins [75] , leading to a decrease in force production and to the establishment of muscle growth defects. Besides an increased proteasomal activity, it was also reported an upregulation in the expression of ubiquitin ligases such as C-terminus of Hsc70 interacting protein (CHIP also known as STUB1), E6-associated protein (E6AP) and MuRF1 (but not MAFbx) and therefore, a build-up in ubiquitinated proteins content, suggesting that this enhanced capacity of UPS might be a response to an increased amount of damaged polypeptides.
Although in other tissues such as the liver, the adipose tissue and the heart [77] it is clear that UPS has less capacity to degrade proteins during aging, however, in muscle this is still controversial, since there are studies reporting an increase [63] or a decrease [60, 78] in proteasomal activity. The underlying reasons for the documented discrepancies can be due to the different models used or the muscle fiber types analyzed. For example, it is known that type II fibers (glycolytic) are more prone to atrophy during aging than type I fibers (oxidative) [23, 79] , therefore, the sort of muscle used might affect the readout of the experiments and further comparisons.
The impact of immunoproteasome in muscle
During infections or atrophy conditions [63, 80] , there is an expression of inducible forms of the 20 S proteasome, the so-called immunoproteasome. It contains three inducible (i) catalytic subunits, named β1i, β2i,and β5i [63] .
Ferrington et al. [81] observed in aged F344BN rats that after proteasomal subunit increased oxidation and decreased content of proteasome-activating proteins relative to 20 S, there was a 2-to 3-fold increase in the 20 S proteasome that corresponded to an increased immunoproteasome induction. However, the observed higher content in the inducible form did not improve the degradation of oxidized proteins. Contrary to these results, Altun et al. [63] , have shown that besides the 2-to 3-fold increase in immunoproteasomes, it represented merely 10% of the total proteasomes in muscles of aged SpragueDawley rats, and therefore did not have a major role in protein degradation.
In 2016, Liu et al. [82] , investigated the role of the immunoproteasome in skeletal muscle atrophy induced by denervation. Using a WT C57BL/6 and an immunoproteasome double knockout lmp7-/-/mecl-1-/-(L7M1) mice, they observed an increase in all of the proteasomal activities and content of standard and immunoproteasome catalytic subunits in both mice strains (especially in WT mice after 7days of denervation). Furthermore, it was observed that the immunoproteasome deficiency led to a change in 26S chymotrypsin-and trypsin-like activities during denervation affecting specific catalytic sites. It also influenced proteasome composition and function, however, it did not blunt the loss of muscle mass and, therefore, seemed to be non essential for protein degradation after denervation. Recently, Baumann et al. [80] , using a WT and the KO model, as mentioned above, also observed in a downhill run exercise, an upregulation of proteasome's catalytic subunits such as LMP7 in WT while β5 was increased in the double KO model. The authors were able to show that after exercise (corresponding to small skeletal muscle injury, yet without inflammation), there was an activation of specific immunoproteasome subunits that when knocked out were replaced by other standard proteasome subunits, suggesting an involvement of immunoproteasome in the regulation of cellular homeostasis maintenance.
The autophagy system in the skeletal muscle
While the role of UPS in muscle aging was reported in several studies, only a few focused on the process of autophagy, a process in which substrates are delivered to lysosomes and degraded by (proteolytic) enzymes. There are three well described types of autophagy in mammalian cells, the chaperone mediated autophagy (CMA), microautophagy and macroautophagy. The first is characterized by the selective degradation of soluble cytosolic proteins translocated to lysosomes mediated by the heat shock cognate protein of 70 kDa (Hsc70). Microautophagy is described by the invagination of the lysosomal membranes directly with the cytosolic material as small vesicles resulting in the degradation in the lysosomal lumen. The third type is named macroautophagy is responsible for removing entire regions of cytosol such as dysfunctional organelles and protein aggregates, after a double membrane vesicle formation, called phaghosome and followed by its fusion with lysosomes where the cargo is normally degraded [83] . In the muscle, macroautophagy (hereafter referred as autophagy) plays a major role in protein degradation.
Interestingly, Wohlgemuth et al. [61] reported an age-dependent decline in autophagic degradation in plantaris muscle from rats. Although the upstream regulator of autophagy, responsible for induction and formation of a pre-autophagosome structure, beclin-1 was increased, a decreased in the microtubule-associated protein 1A/1B-light chain 3 gene and protein (LC3) was described. LC3 is an essential protein for the early autophagosome expansion. After being cleaved by the protease Atg4, becomes LC3B-I, a cytosolic form which then becomes lipidated with a phosphoethanolamide molecule and is converted into LC3B-II (a common marker for autophagosome formation). Moreover, the lysosome-associated membrane protein 2 (LAMP-2) mRNA levels were also found to be reduced, suggesting a decline in the process of lysosomal degradation during aging. LAMP-2 is an important receptor at the lysosomal membrane, required for the fusion of autophagosomes and lysosomes. The influence of aging on muscle capacity for autophagy was also studied in gastrocnemius tissue from mice and rats [84] . Penna et al. found a decrease in beclin-1, and LC3B-I proteins, while LC3B-II was unchanged, in 22-month old mice compared to 3-month old mice (Table 1 ). In addition, p62 protein (also named SQSTM1), was increased. The p62 protein can be used as a marker of substrate sequestration that links ubiquitinated substrates to the autophagic machinery and normally accumulates when autophagy is inhibited [84, 85] . In old rats was also shown an accumulation of p62, suggesting a reduction in autophagic-lysosomal degradation [84] . Again, the decline of muscle autophagy clearly seems to be responsible for muscle atrophy as shown by Masiero et al. [74] . After establishing in mice a muscle-specific KO of autophagy-related protein 7 (Atg7, participates in the formation and expansion of the autophagosome), they observed deep muscle atrophy and age-dependent decrease in strength. Further evidence for the important role of the lysosomal system in muscle mass maintenance was obtained after autophagy was induced by caloric restriction (CR) in which old mice recovered from the loss of muscle mass, showing that muscle mass loss can be ameliorated by genetic or environmental approaches such as diet regimes. In contrast to that, autophagy-related markers in young (27-years old) and old (70-years old) human vastus lateralis muscle samples were not changed [86] . Thus, the influence of aging on muscle autophagy requires further investigations in order to have a clearer picture in human skeletal muscle aging. Nevertheless, as stated above, there is evidence pointing to the decline of autophagy during muscle aging.
Furthermore, the decline of autophagy can increase the risk for the accumulation of intracellular waste products, such as oxidized lipids and proteins resulting in insoluble protein aggregates such as lipofuscin (composed mainly by oxidized proteins but also lipids and carbohydrates), which is a common feature of aged cells and tissues [66, 87] .
The presence of aggregates in human aged muscle was confirmed when comparing old human vastus lateralis muscles with young control samples, where a 2.1 fold increase in protein aggregates was found in the old samples. The authors then performed in nematodes by means of RNAi approach the knock down (KD) of some of the human orthologs, where they showed that reducing proteins responsible for aggregates formation (found in humans) was able to decrease protein aggregates, maintain muscle mass and ameliorate the mobility in C. elegans [48] . Moreover, the accumulation of lipofuscin was also found in skeletal muscle fibers of old Sprague-Dawley rats and one factor causing its accumulation is certainly the decline of autophagy, reinforcing its importance for cellular proteoastasis [63] . Moreover, the formation of protein aggregates due to decreased proteasome activities was studied by Kitajima and colleagues [75] , in a muscle-specific Rpt3 KO model in young adult mice. Interestingly, they observed an accumulation of abnormal inclusions with an apparently increase in autophagy but impaired autophagosomal formation, leading to myofiber degeneration and loss of muscle mass.
An important consequence arising from impaired proteolytic systems is the elevated levels of misfolded and/or dysfunctional proteins which may result in stress to the endoplasmatic reticulum. It is widely described, that upon ER stress there is globally a shut down in protein translation to avoid the occurrence of further misfolded proteins that would lead to an unsustainable pressure to the cellular machinery. Under these conditions the pro-apoptotic marker, CHOP and other apoptotic markers such as caspase-3 and caspase-9 can trigger cell death by the process of apoptosis [61, 62] .
A balanced ubiquitin-proteasome and lysosomal-autophagy systems capacity is therefore important and beneficial for cellular cleansing and normal cellular function, and here we reviewed several studies that elucidate the importance of an active and functional proteostasis dynamic equilibrium.
The role of calorie restriction in proteolytic systems
As already mentioned, calorie restriction (CR) is generally recognized as a lifespan extension intervention by amelioration or recovering age-related changes. Here, we decided to briefly describe some interactions of the CR outcomes in the skeletal muscle proteolytic systems.
Studies have shown that autophagic and proteasomal activity decline during aging and might contribute to age-related muscle loss. However, there is evidence that CR increases the activity of these cellular quality control processes by preventing the accumulation of oxidized proteins characteristic of the aging process [88] According to Marzetti [89] , decreasing food intake, leads to a strong induction of autophagy, since it activates phosphoinositide 3-kinase class III protein(PI3K-III) through a complex formation with Beclin-1 and/or downregulation of the nutrient-sensor mTOR. In mice, CR was found to induce the expression of 19 S proteasome subunit psmc3/Rpt5 and PA28α (proteasome activator). In this study, CR seemed sufficient to improve autophagic potential through the activation of AMPK [90] . Interestingly, a study with neonatal calves have shown a decrease in skeletal muscle mass after calorie restriction, due to a reduction in fiber size. This reduction was associated with increased calpain 1 activity (another muscle proteolytic system) and complemented with lower expression of calpastatin (the endogenous regulator of calpain 1). CR also attenuated protein synthesis since it led to a reduction in total glycogen synthase kinase-3β (GSK3β) and its phosphorylation when comparing with the control goup. However, the E3 muscle specific ligases as well as autophagy markers were not affected by CR [91] , which suggests coordinated regulation of specific proteins or pathways.
Hepple et al. [71] , compared rat plantaris muscle from 8, 25 and 30 months old ad libitum and in CR interventions. They were able to show that CR rats had less accumulation of protein carbonyls during aging as well as higher chymotrypsin-like activity, even if without changes in the content of E3 ligases. Selsby et al. [92] , also investigated similar male Fisher 344 rats' ages (12months old and 26-28months old ad libitum and life-long CR). They found significant higher levels of trypsinlike activity in CR intervene rats than in old ones, however, without significant changes in the chymotrypsin-like activity.
It is known that Hsps, closely interact with the 20S proteasome and interestingly, their levels were significantly less expressed in old animals when compared to adult or old-CR intervened animals.
Worthy of mention is that also in human skeletal muscle, from 3 to 15 years on a CR intervention, Hsp70 (responsible for the folding of misfolded or denaturated proteins), was found to be highly expressed when compared to a control group. Regarding autophagy markers such as Beclin-1 and LC3 mRNA and protein levels, were upregulated too [93] .
Together, these findings suggest that calorie restriction induces the upregulation of several heat shock proteins that have a crucial role in protein homeostasis and quality control which may be involved in slowing the rate of aging and protecting against age-associated diseases [94] .
Redox regulation of proteostasis
In the chapters above we described the dramatic changes through which the UPS and the ALS undergo during aging (Fig. 1) . It is, however, interesting why such changes occur. Certainly, there are multiple reasons, as age-related genetic changes combined with a reduced recovery of the genome of a muscle fiber by satellite cells, environmental influences or metabolic changes throughout life. Since the principles of the free radical theory of aging in its various variations [95] [96] [97] is somehow a likely scenario for age-related changes in metabolism, redox-related changes of proteostasis, it seems to be of major importance accounting for the loss of muscle, and the more so, because proteolytic systems are under tight redox regulation. This was especially well demonstrated for the UPS.
One of the major features regulating the proteolytic protein turnover in cells is the modification of the substrate protein itself, so that moderate oxidation increases proteolytic susceptibility, whereas contrary to this, severe oxidation and resulting aggregates have a negative effect on protein turnover [98] [99] [100] [101] [102] . The increased proteolytic susceptibility of moderately oxidized proteins is due to the unfolding of the substrate protein [103] . However, this is true for the proteolytic susceptibility towards the 20 S proteasome, whereas a modification of lysine residues in substrate proteins might reduce the ubiquitination sites and, therefore, decrease the degradation of a certain substrate.
However, since the UPS components are proteins themselves, the UPS undergoes redox-related changes. It was consistently reported, that the 26 S proteasome is vulnerable to oxidative stress, whereas the 20 S proteasome is relatively resistant [104, 105] . Sometimes a moderate increase of the 20 S proteasome activity is observed and this is perhaps due to a binding of the 11S regulator. If oxidative stress is sub-lethal, the 26 S proteasomal activity is quickly recovered, most likely with the support of the chaperone HSP70 [106] . The chemical basis of these reactions is largely unknown, however, it was recently shown that a reversible thiol oxidation of the proteasome takes place, regulating its activity [107, 108] . Additionally, S-glutathionylation was reported to regulate the access of the substrate to the active centers of the proteasome [109] . Besides such reversible modification a multitude of various non-enzymatic, non-reversible modifications are reported to occur on the proteasome, reducing the activity of the enzymes. This includes protein carbonylation, nitration, HNE-modification and glycoxidation [110] .
Interestingly, not only the proteasomes but the ubiquitination machinery is redox sensitive as well, as shown for a number of E1, E2 and E3 enzymes containing thiol groups and readily inactivated during oxidative stress [111] .
One of the major functions requiring protein degradation in aging and oxidative stress is the prevention of protein aggregation. However, upon formation, protein aggregates are no longer seen as inert waste Fig. 1 . Redox changes during aging affect proteostasis and function in the skeletal muscle. In the early period of life (upper panel) proteostasis is maintained by several mechanisms in order to avoid not only the accumulation of misfolded, oxidized and aggregated proteins but also damaged organelles. Proteolytic processes such as proteasomal and lysosomal systems play a pivotal role in ensuring proteostasis by mainly coordinating the cellular degradation events, promoting skeletal muscle function and mass. However, during aging, several reports have shown alterations such as impaired proteostasis in the muscle (bottom panel). This is likely attributed to the low steady-state increase in oxidative stress that disrupts cellular redox signaling and affects both proteasomal and autophagy processes. As a consequence, proteostasis lost as shown by the detrimental accumulation of protein aggregates and damaged organelles such as mitochondria. The outcome is a skeletal muscle displaying impaired function and loss in mass that affects life's quality. The whole body metabolism is likely to be affected too.
products accumulating in a cell, but can actively disturb cellular metabolism by inhibiting the proteasome [112] [113] [114] [115] , leading to increased oxidative stress [116] and disrupting cellular signaling [117] [118] [119] . This might play a role in the development of diseases such as Alzheimer's disease [118, 120] or shorten the life span on at least animal models [121] .
Interestingly, in the first measurements of proteasomal expression during and after oxidative stress no change in proteasomal subunits amount was found [98, 99] as it was verified during senescence [122] . However, later more detailed experimental set-ups demonstrated that at least some of the proteasomal subunits are induced largely by the transcription factor Nrf2 (Nuclear factor (erythroid-derived 2)-like 2) promoting the expression of the subunits via the EpRE-(or ARE) elements [123] . This also seems to be true for some proteasomal regulator subunits [123] . Other subunits of the proteasome, as those for the immunoproteasome, can be regulated by the JAK/STAT pathway [124] .
Therefore, the proteasomal system is highly regulated during oxidative stress by various redox-regulated processes. Since aging is accompanied by modulation of redox status within the muscle the multitude of the observed changes in muscle proteostasis might be due to redox-related changes. Much less detail is known about the changes of the ALS in oxidative stress and aging, however, recent work points on a central role of mTOR in the age-related loss of autophagy, while the lysosomal capacity seems to be stable or even increased [122, 125, 126] .
5. Modulating muscle wasting: a role for protein intake, physical activity and proteasome activators?
With aging, inflammation rises, an event known as "inflammaging" and with it, proinflammatory markers, such as IL-6 and TNF-α are upregulated and are observed in the blood from elderly people. Inflammaging can be detected in muscle by quantification of infiltrating macrophages and/or cytokines [127] .
Therefore, and to counteract the detrimental effects of aging and inflammation, Draganidis et al. [127] , have shown that some proteins, from whey, soy and isoflavone-enriched soy proteins, have a high nutritional impact due to their amino acid composition, absorption kinetics and antioxidant capacity. These proteins are able to increase and enhance the activity of oxidative enzymes like glutathione peroxidase, catalase and SOD. With ROS levels improvement, the capacity of protein degradation might be improved as well and cell cleansing maintained.
Moreover, another study from Draganidis, compared the vastus lateralis muscle from 11 subjects, after 2 and 8 days acute bout exercise, with and without a milk protein intervention (after exercise). They could demonstrate that milk protein (sulphur-containing amino acid) could maintain chymotrypsin-like activity after 2 days, while in control group there was a decrease around 30%. With this, they showed that under severe inflammation, protein intake can improve proteasomal degradation [128] .
It still remains to be elucidated how protein intake would improve muscle of elderly people, since most of the studies are performed in young/adult subjects. One should not forget that elderly people eat slowly and smaller meals, leading significantly to energy decline. Therefore, the benefits of protein intake may vary depending on age, exercise program and status of the subjects [129] .
In order to reach out worldwide population regarding muscle wasting (since special groups of people, like elderly or handicap, cannot perform exercise or eat properly), studies such as the one performed by Jones et al. [130] , are now bringing evidence of new a pharmacological approach to improve UPS. They were able to show that chlorpromazine (neuroleptic agent), can enhance the 20 S proteasomal activity by inducing the open-gate 20 S conformation and therefore enhance turnover [130] .
Also, Katsiki et al. [131] have shown that a natural compound, oleuropein (extracted from Olea Europa leafs), could not only promote an increase in proteasomal activity in primary fibroblasts (by gate opening modulation), but also create an elevated cellular resistance to oxidative stress, providing a cellular lifespan extension [131] . Nevertheless, according to the literature, there are not yet a big variety of drugs described that can directly activate the proteasomal catalytic activity. Therefore to our current knowledge, neither in vitro or in vivo studies were done with these or other compounds in the muscle.
Conclusions
This review summarizes the effects of the loss of proteostasis during muscle aging. It is clear that the UPS and ALS become dysregulated over time and this is strongly associated with muscle impairment. However, more questions need to be addressed experimentally. For example, why do the different fiber types have different susceptibilities to the aging process? How is proteostasis regulated in these fibers? How exactly oxidative stress or redox shifts play a role? Further work needs to be done in order to answer these and other questions. The importance of unraveling how and why proteostasis is affected is of utmost importance since many studies are now shedding light on how the skeletal muscle is no longer just a simple reservoir for amino acids, but also as an active player in regulating whole body metabolism. Furthermore, understanding aging in skeletal muscle will certainly contribute to an improvement in the human population healthspan.
